Agile therapeutics reports first quarter 2024 financial results and provides corporate update

First quarter net revenue increased 58% and factory sales increased 3% from fourth quarter 2023 twirla first quarter 2024 demand rebounded 18% from fourth quarter 2023 princeton, n.j., may 15, 2024 (globe newswire) -- agile therapeutics, inc. (pink: agrx), a women's healthcare company, today reported financial results for the three months ended march 31, 2024 and provided a corporate update.
AGRX Ratings Summary
AGRX Quant Ranking